期刊文献+

Maspin和VEGF-C蛋白表达与卵巢癌发生及临床病理学的关系 被引量:4

Expression of Maspin and VEGF-C protein in human ovarian carcinoma and its relationship with clinicopathological variables
下载PDF
导出
摘要 目的研究Maspin和VEGF-C蛋白表达与卵巢癌的发生和临床病理因素的相关性。方法应用免疫组织化学技术检测60例卵巢癌(卵巢乳头状浆液性癌33例、卵巢子宫内膜样癌7例、卵巢黏液性癌20例)、18例良性上皮性卵巢肿瘤、14例交界性卵巢肿瘤标本及10例正常卵巢组织中Maspin和VEGF-C的蛋白表达,并进行对照比较。结果 Maspin和VEGF-C在卵巢癌中的阳性表达率分别为65.0%和68.3%,与卵巢交界性肿瘤、良性肿瘤、正常卵巢组织相比较,差异具有统计学意义(P<0.05);卵巢癌组织中,Maspin的表达与病理类型、分化程度无相关性(r=0.125,P=0.34;r=-0.037,P=0.778),与FIGO临床分期、淋巴结转移、腹水密切相关(r=-0.364,P=0.004;r=0.311,P=0.015;r=-0.292,P=0.024)。VEGF-C的表达与淋巴结转移、FIGO临床分期、腹水有相关性(r=-0.280,P=0.031;r=0.377,P=0.003;r=0.384,P=0.002)。Maspin与VEGF-C蛋白表达呈负相关(r=-0.349,P=0.006)。结论卵巢癌细胞中Maspin和VEGF-C蛋白均有较高水平表达,可能在卵巢癌的血管发生、进展、淋巴结转移中发挥着重要作用。联合检测卵巢癌中Maspin和VEGF-C蛋白的表达,有利于更好地评估卵巢癌的生物学行为,提高对患者预后判断的准确性。 Objective To investigate the expression and correlation between Maspin,VEGF-C and the tumor genesis of the ovary,clinical-pathological variables.Methods Using immunohistochemistry,Maspin and VEGF-C expression of 60 ovarian carcinoma tissues(33 serous papillary carcinomas,7 endometrioid carcinomas,and 20 ovarian mucinous carcinomas) and 18 benign ovarian tumors,14 borderline ovarian tumors and 10 normal ovarian tissues were examined and compared.Results The positive expression rates of Maspin and VEGF-C were 65.0%and 68.3%respectively,there were significant difference between these expression in tissues of ovarian carcinoma and borderline carcinoma,benign tumor,normal ovarian tissues;over expression of Maspin was not correlated with pathological type and the degree of differentiation(r =0.125,P = 0.34;t = -0.037,P =0.778),but it was correlated with International Federation of Gynecology and Obstetrics(FIGO) stage,presence of metastatic lymph nodes,and the presence of ascites(r = -0.364,P =0.004;r =0.311,P =0.015; r = - 0,292,P = 0.024).Over expression of VEGF-C was correlated with presence of metastatic lymph nodes,FIGO stage, and the presence of ascites(r = -0.280,P =0.031;r =0.377,P =0.003;r =0.384,P = 0.002).Maspin was negatively correlated with VEGF-C(r = -0.349,P =0.006).Conclusion Over expression of Maspin and VEGF-C was detected in ovarian carcinoma.High expression of Maspin and VEGF-C are seemed to play a role in ovarian cancer angiogenesis, progression and lymph node metastases.Combination detection the expressions of Maspin and VEGF-C is helpful for evaluating the biological characteristics and predicting the prognosis of ovarian carcinoma.
作者 杨娜 安牧尔
出处 《疑难病杂志》 CAS 2012年第4期274-276,F0003,共4页 Chinese Journal of Difficult and Complicated Cases
关键词 卵巢癌 MASPIN VEGF-C 免疫组化 Ovarian tumor Maspin VEGF-C Immunohistochemistry
  • 相关文献

参考文献14

  • 1Onogawa S,Kitadai Y,Tanaka S. Expression of VEGF-C andVEGF-D at the invasive edge correlates with lymphnode metastasis and prognosis of patients with colorectal carcinoma[J].Cancer,2004,(01):32-39.
  • 2Zou Z,Anisowicz A,Hendrix MJ. Maspin,a serpin with tumor-suppressing activity in human mammary epithelial cells[J].Science,1994,(5146):526-529.
  • 3Payne CM,Holubec H,Crowley-Skillicorn C. Maspin is a deoxycholate-inducible,anti-apoptotic stress-response protein differentially expressed during colon carcinogenesis[J].Clin Exp Gastroenterol,2011.239-253.
  • 4Narayan M,Twining S. Focus on molecules:maspin[J].Experimental Eye research,2010,(01):2-3.doi:10.1016/j.exer.2009.07.003.
  • 5马瑛,彭芝兰.上皮性卵巢癌中Maspin的表达及其与血管生成的关系[J].四川大学学报(医学版),2009,40(2):223-227. 被引量:1
  • 6Nawata S,Shi HY,Sugino N. Evidence of post-translational modification of the tumor suppressor maspin under oxidative stress[J].International Journal of Molecular Medicine,2011,(02):249-254.
  • 7Kitadai Y,Amioka T,Haruma K. Clinicopathological significance of vascular endothelial growth factor(VEGF-C)in human esophageal squamous cell carcinoma[J].International Journal of Cancer,2001,(05):662-666.
  • 8Solomon LA,Munkarah AR,Schimp VL. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer[J].Gynecologic Oncology,2006,(03):385-389.
  • 9孙翠芬,杨静华,董晓瑜,彭汝格.可溶性CD44v6、VEGF检测在结核性腹水和卵巢癌性腹水鉴别诊断中的价值[J].疑难病杂志,2011,10(4):275-277. 被引量:3
  • 10乔丽娟,封全灵,赵静.上皮性卵巢癌中Maspin、p27表达的相关性及意义[J].中国妇幼保健,2010,25(10):1382-1384. 被引量:3

二级参考文献54

  • 1朱宝和,詹文华,刘弋,马晋平,李正荣.PTEN与基质金属蛋白酶在胃癌组织中的表达及意义[J].中国现代普通外科进展,2006,9(1):33-36. 被引量:8
  • 2罗波,隋媛,丁艳,宋保连,郝建波.CD_(44)v6和上皮钙黏蛋白在膀胱移行细胞癌中的表达及意义[J].中国全科医学,2006,9(20):1675-1677. 被引量:8
  • 3Hojo T, Akiyama Y, Nagasaki K,etal. Association of Maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues. Cancer Lett,2001 ,171(1):103-110.
  • 4Tahmatzopoulos A, Sheng S, Kyprianou N, et al. Maspin sensitizes prostate cancer ceils to doxazosin-induced apoptosis. Oneogene, 2005,24(34) : 5375-5383.
  • 5Lefter LP, Sunamura M, Furukawa T, et al. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype. Clin Cancer Res, 2003 , 9 (13) 5044-5052.
  • 6Sood AK, Fletcher MS, Gruman LM,et al. The paradoxical expression of Maspin in ovarian carcinoma. Clin Cancer Res, 2002,8(9) :2924-2932.
  • 7Weidner N, Folkman J. Tumoral vascularity as a prognostic factor in cancer patients, the evidence continues to grow. J Pathol, 1998 ,184 (2) : 119-122.
  • 8Zou Z, Anisowiez A, Hendrix MJC, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science, 1994 ~263(5146) ,526-529.
  • 9Shi HY, Zhang W, Liang R,et al. Blocking tumor growth, invasion, and metastasis by Maspin in a syngeneic breast cancer model. Cancer Res,2001,61(18) :6945-6951.
  • 10Latha K, Zhang WG, Celia N, et al. Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Molecular and Cellular Biology,2005 ,25(5):1737-1748.

共引文献53

同被引文献49

  • 1刘秀芳,王炳胜,熊正文,李宏伟.微血管密度及增殖细胞核抗原表达与宫颈癌放射敏感性的关系初探[J].中国肿瘤临床与康复,2005,12(2):100-102. 被引量:5
  • 2高鹏,王培戈,范晓琳,崔铮,陈咸增.Maspin和E-cadherin蛋白表达与胃癌临床病理学的关系[J].山东医药,2007,47(6):30-31. 被引量:3
  • 3何常,陈佳,钟愉,张维元.结直肠癌内ETS-1、血管内皮生长因子C蛋白表达及微血管和微淋巴管密度的意义[J].中华病理学杂志,2007,36(5):331-332. 被引量:3
  • 4Cheng Y,Zhou Y,Jiang W J,et al.Significance of E-cadherin,β-catenin,and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma[J].Hum Pathol,2012,43(8):1213-1220.
  • 5Lin Z,Liu Y,Sun Y,et al.Expresssion of Ets-1,Ang-2 and maspin in ovarian cancer and their role in tumor angiogenesis[J].J Exp Clin Cancer Res,2011,30(9):31-37.
  • 6Song S H,Park H M,Eom D W,et al.The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins[J].Int J Gynecol Cancer,2007,17(4):858-867.
  • 7Pap Z,Pavai Z,Denes L,et al.An immunohistochemical study of colon adenomas and carcinomas:E-cadherin,Syndecan-1,Ets-1[J].Pathol Oncol Res,2009,15(4):579-587.
  • 8Yeasmin S,Nakayama K,Rahman M T,et al.Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes[J].Gynecol Oncol,2010,117(3):409-416.
  • 9Murakami A,Fukushima C,Yoshidomi K,et al.Suppression of carbonyl reductase expression enhances malignant behaviour in uterine cervical squamous cell carcinoma:Carbonyl reductase predicts prognosis and lymph node metastasis[J].Cancer Lett,2011,311(1):77-84.
  • 10Zhang M,Volpert O,Shi Y H,et al.Maspin is anangiogenesis inhibitor[J].Nat Med,2000,6(2):196-199.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部